Is Walgreens Boots Alliance, Inc. (WBA) a good buy?

Ausiliatrice Cristiano
Luglio 14, 2017

WBA has been the subject of several other research reports.

SM Energy Company has a consensus outperform rating from 23 Wall Street analysts, and the number of shares now sold short amount to at least 12.82% of shares outstanding. Finally, Barclays PLC set a $79.00 price target on Walgreens Boots Alliance and gave the stock a "hold" rating in a research report on Saturday, April 1st. The company now has an average rating of "Buy" and a consensus price target of $90.47. (NASDAQ:WBA) traded up 0.63% during midday trading on Thursday, reaching $78.01. The stock showed weekly downbeat performance of -1.42%, which was maintained for the month at -5.42%. Walgreens Boots Alliance, Inc. has a one year low of $75.18 and a one year high of $88.00.

The stock is now moving with a Negative distance from 200-Day Simple Moving Average of about -6.28% and has no so good Year to Date (YTD) Performance of -6.33% which means the stock is constantly adding to its value from previous fiscal year end price. The company's market cap is $83.94 Billion, and the average volume is 4.88 Million.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Thursday, June 29th. The pharmacy operator reported $1.33 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $1.30 by $0.03. The firm had revenue of $30.12 billion during the quarter, compared to analyst estimates of $29.72 billion.

Quarterly Revenue growth year over year is 2.1 Percent. During the same period in the previous year, the firm earned $1.18 earnings per share. On average, equities analysts expect that Walgreens Boots Alliance will post $5.01 EPS for the current year. Finally, Deutsche Bank AG reissued a "buy" rating and issued a $92.00 price target on shares of Walgreens Boots Alliance in a report on Wednesday, March 22nd. (NASDAQ:WBA) stock have an ABR of 1.46. If you are accessing this news story on another site, it was stolen and reposted in violation of United States & global copyright & trademark law. The original version of this report can be viewed at https://baseballnewssource.com/markets/walgreens-boots-alliance-inc-nasdaqwba-now-covered-by-needham-company-llc-updated/1121380.html.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 12th. The dividend was $0.375 per share for the quarter which is $1.50 annualized. The ex-dividend date is Wednesday, August 16th. This is a boost from Walgreens Boots Alliance's previous quarterly dividend of $0.38. Walgreens Boots Alliance's payout ratio is presently 37.78%.

In related news, Director William C. Foote sold 2,736 shares of Walgreens Boots Alliance stock in a transaction that occurred on Wednesday, May 3rd. The shares were sold at an average price of $85.89, for a total transaction of $234,995.04. Clinton Group Inc now owns 38,599 shares valued at $3,205,000. The sale was disclosed in a filing with the SEC, which is available through the SEC website.

Several institutional investors have recently modified their holdings of the stock.

Turning to Walgreens Boots Alliance, Inc. Hudock Capital Group LLC raised its stake in shares of Walgreens Boots Alliance by 0.4% in the first quarter.

The volume of the particular stock is the shares bought and sold in a single trading day. Webster Bank N.A. increased its stake in shares of Walgreens Boots Alliance by 18.4% in the first quarter. Tarbox Group Inc. now owns 1,355 shares of the pharmacy operator's stock worth $113,000 after buying an additional 1,006 shares during the period. Howe & Rusling Inc. increased its position in shares of Walgreens Boots Alliance by 209.2% in the first quarter. Howe & Rusling Inc. now owns 1,441 shares of the pharmacy operator's stock valued at $120,000 after buying an additional 975 shares during the period. Tesco Pension Investment Ltd owned 0.12% of Walgreens Boots Alliance worth $109,688,000 at the end of the most recent quarter. Webster Bank N.A. now owns 1,509 shares of the pharmacy operator's stock worth $125,000 after buying an additional 235 shares in the last quarter. Following the sale, the director now owns 21,887 shares of the company's stock, valued at $1,879,874.43.

On October 17 the company was upgraded from "Hold" to "Buy" in a statement from Jefferies.

Altre relazioni OverNewsmagazine

Discuti questo articolo

SEGUI I NOSTRI GIORNALE